OncoVision Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.65M

  • Investors
  • 3

OncoVision General Information

Description

Developer of medical imaging devices designed to support doctors in the treatment of cancer. The company's device transforms the cure of cancer through the creation of new standard diagnostic tests and treatments in multimodal molecular vision technologies for surgery, intervention, and advanced research with clinical and economic advantages, enabling healthcare professionals to use imaging technologies that result in improved patient life quality.

Contact Information

Website
www.oncovision.com
Formerly Known As
GEM Imaging
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/Jeronimo de Monsoriu
  • 92. Bajo izquierda
  • 46022 Valencia
  • Spain
+34 963
Primary Industry
Diagnostic Equipment
Vertical(s)
Oncology
Corporate Office
  • C/Jeronimo de Monsoriu
  • 92. Bajo izquierda
  • 46022 Valencia
  • Spain
+34 963

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoVision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 18-Jan-2022 $2.65M Completed Generating Revenue
4. Secondary Transaction - Private Completed Startup
3. Later Stage VC 01-Jan-2013 Completed Startup
2. Later Stage VC 23-May-2012 $3.89M $3.89M Completed Startup
1. Early Stage VC 01-Aug-2006 Completed Startup
To view OncoVision’s complete valuation and funding history, request access »

OncoVision Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class A
To view OncoVision’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

OncoVision Patents

  • 60

    Total Documents Applications and Grants

  • Total Patents Families

  • 36

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

OncoVision Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2939157-B2 Reading network topology for positron emission tomography devices with time of flight Active 12-Oct-2021
ES-2939157-A1 Reading network topology for positron emission tomography devices with time of flight (machine-translation by google translate, not legally binding) Active 12-Oct-2021
EP-4418019-A1 Readout network topology for positron emission tomography devices with time of flight Pending 12-Oct-2021
EP-4418019-A4 Readout network topology for positron emission tomography devices with time of flight Pending 12-Oct-2021
WO-2023062263-A1 Readout network topology for positron emission tomography devices with time of flight Inactive 12-Oct-2021 A61B6/037
To view OncoVision’s complete patent history, request access »

OncoVision Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoVision Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
INNVIERTE SICC Government Minority
Techstars Accelerator/Incubator Minority
Bullnet Capital Venture Capital Minority
To view OncoVision’s complete investors history, request access »

Ready to get started?

Request a free trial

OncoVision FAQs

  • When was OncoVision founded?

    OncoVision was founded in 2002.

  • Where is OncoVision headquartered?

    OncoVision is headquartered in Valencia, Spain.

  • What is the size of OncoVision?

    OncoVision has 26 total employees.

  • What industry is OncoVision in?

    OncoVision’s primary industry is Diagnostic Equipment.

  • Is OncoVision a private or public company?

    OncoVision is a Private company.

  • What is the current valuation of OncoVision?

    The current valuation of OncoVision is .

  • What is OncoVision’s current revenue?

    The current revenue for OncoVision is .

  • How much funding has OncoVision raised over time?

    OncoVision has raised $6.53M.

  • Who are OncoVision’s investors?

    INNVIERTE SICC, Techstars, and Bullnet Capital have invested in OncoVision.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process